We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
+23.69%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$5.7B
AUM Growth
-$3.24B
Cap. Flow
-$3.84B
Cap. Flow %
-67.41%
Top 10 Hldgs %
65.27%
Holding
186
New
39
Increased
32
Reduced
32
Closed
63

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$294M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$157M
3
STOR
STORE Capital Corporation
STOR
+$75.8M
4
DEN
Denbury Inc.
DEN
+$54.1M
5
KNBE
KnowBe4, Inc. Class A Common Stock
KNBE
+$46.7M

Top Sells

Rank Stock Value
1
TWTR
Twitter, Inc.
TWTR
+$1.03B
2
TRQ
Turquoise Hill Resources Ltd
TRQ
+$855M
3
AVLR
Avalara, Inc.
AVLR
+$434M
4
CTXS
Citrix Systems Inc
CTXS
+$421M
5
ZEN
ZENDESK INC
ZEN
+$319M

Sector Composition

Rank Sector Weight
1 Technology 18.18%
2 Healthcare 9.86%
3 Industrials 6.84%
4 Communication Services 6.45%
5 Real Estate 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RXRX icon
76
Recursion Pharmaceuticals
RXRX
$1.73B
$3.08M 0.05%
400,000
+100,000
+33% +$981K
VICI icon
77
VICI Properties
VICI
$29.4B
$3.08M 0.05%
95,000
-20,000
-17% -$643K
MRVL icon
78
CALL
Marvell Technology
MRVL
$196B
$2.96M 0.05%
80,000
– –
MIR icon
79
Mirion Technologies
MIR
$3.91B
$2.94M 0.05%
445,000
-105,000
-19% -$707K
ACI icon
80
Albertsons Companies
ACI
$5.83B
$2.7M 0.05%
+130,000
New +$2.86M
CRBG icon
81
Corebridge Financial
CRBG
$15B
$2.51M 0.04%
125,000
+45,000
+56% +$950K
DJT icon
82
Trump Media & Technology Group
DJT
$2.83B
$2.42M 0.04%
161,191
-807,384
-83% -$15.8M
WMB icon
83
Williams Companies
WMB
$86.1B
$2.3M 0.04%
70,000
– –
ALIT icon
84
Alight
ALIT
$407M
$2.09M 0.04%
+12,500
New +$2.08M
RBA icon
85
CALL
RB Global
RBA
$17.5B
$2.02M 0.04%
+35,000
New +$2.04M
KRTX
86
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.97M 0.03%
10,000
+3,500
+54% +$751K
STRO icon
87
Sutro Biopharma
STRO
$421M
$1.82M 0.03%
22,500
-13,500
-38% -$938K
SYF icon
88
Synchrony
SYF
$25.6B
$1.81M 0.03%
55,000
– –
NXPI icon
89
NXP Semiconductors
NXPI
$60.4B
$1.5M 0.03%
9,500
– –
BAC icon
90
Bank of America
BAC
$442B
$1.32M 0.02%
40,000
– –
DIS icon
91
CALL
Walt Disney
DIS
$181B
$1.3M 0.02%
15,000
-30,000
-67% -$2.87M
AMLX icon
92
Amylyx Pharmaceuticals
AMLX
$2.54B
$1.29M 0.02%
+35,000
New +$1.24M
CORS.U
93
DELISTED
Corsair Partnering Corporation Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CORS.U
$1.24M 0.02%
125,700
– –
STRO icon
94
PUT
Sutro Biopharma
STRO
$421M
$1.13M 0.02%
+14,000
New +$973K
RNLX
95
DELISTED
Renalytix plc American Depositary Shares
RNLX
$1.12M 0.02%
600,000
-116,824
-16% -$182K
PLTK icon
96
Playtika
PLTK
$1.12B
$1.06M 0.02%
124,232
-475,768
-79% -$4.41M
VIVO
97
DELISTED
Meridian Bioscience Inc
VIVO
$996K 0.02%
+30,000
New +$966K
MBLY icon
98
Mobileye
MBLY
$2.2B
$877K 0.02%
+25,000
New +$759K
MBLY icon
99
PUT
Mobileye
MBLY
$2.2B
$877K 0.02%
+25,000
New +$759K
ESPR
100
DELISTED
Esperion Therapeutics
ESPR
$873K 0.02%
140,127
-114,965
-45% -$822K
2 3
4
5 6

Similar funds

CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return

Pentwater Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Pentwater Capital Management held 186 positions worth $5.7B, down 36% from $8.94B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Pentwater Capital Management withdrew a net $3.84B in Q4 2022, closing 63 positions and reducing 32 holdings. Its most notable exit was Twitter, Inc., an estimated $1.03B position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Pentwater Capital Management opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $403M.

  • Pentwater Capital Management's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 3,539,656 shares worth $403M.
  • Pentwater Capital Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $157M increase.
  • Pentwater Capital Management's biggest Q4 2022 reduction was TEGNA Inc, cutting an estimated $118M.
  • Pentwater Capital Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $1.03B.
  • Pentwater Capital Management's ten largest holdings make up 65% of its $5.7B portfolio in Q4 2022.
  • Pentwater Capital Management opened 39 new positions and closed 63 in Q4 2022.
  • Pentwater Capital Management's portfolio value fell 36% quarter-over-quarter to $5.7B.

Based on Pentwater Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.